After a tumultuous year, a popular virtual care platform is trying its hand in a competitive blood testing market.

The telehealth platform expects the new offering to add to its user base as it draws customers looking to prevent future ...

Hims & Hers delivered yet another strong quarter of revenue growth in Q3, with sales climbing 49% year over year to $599 ...

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of Labs, a new ...

This week, the parents of Luke Tyler, the Washington State University (WSU) freshman who was found dead in his dorm room on January 22, 2023, filed a wrongful death lawsuit in the King County Superior ...

Hims & Hers launches Labs, offering annual biomarker testing plans with doctor-developed guidance and expanded diagnostics planned across key health categories.

Hims & Hers Health (HIMS) stock is in focus as the firm launches Labs, a product offering preventive care through insights ...

Although Hims & Hers Health has tanked in the past month, the quantitative profile suggests a contrarian trade is brewing for ...

The parents of Luke Tyler, a WSU freshman found dead in his dorm, allege his death was a consequence of Hims' reckless ...

Hims & Hers Health, Inc. could see more upside in partnerships and international expansion. Click here to read an analysis of ...

Hims & Hers Health’s third quarter results prompted a positive market reaction as the company delivered strong revenue growth ...

The telehealth platform will allow customers to access testing at more than 1,000 Quest Diagnostics locations nationwide. After testing, users will receive results and consult with providers on the ...